|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0013216,
umls-concept:C0038952,
umls-concept:C0278846,
umls-concept:C0600558,
umls-concept:C0871261,
umls-concept:C0936012,
umls-concept:C1514923,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2698872,
umls-concept:C2911692
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2010-10-7
|
|
pubmed:abstractText |
Cell-cycle protein (p27, p21, and p53) expression can predict response to neoadjuvant chemotherapy and prognosis in some neoplasms. This study evaluated whether these markers could also be effective in invasive thymoma during a multimodality treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1534-4681
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3022-9
|
|
pubmed:meshHeading |
pubmed-meshheading:20567922-Antineoplastic Agents,
pubmed-meshheading:20567922-Combined Modality Therapy,
pubmed-meshheading:20567922-Female,
pubmed-meshheading:20567922-Humans,
pubmed-meshheading:20567922-Male,
pubmed-meshheading:20567922-Middle Aged,
pubmed-meshheading:20567922-Neoadjuvant Therapy,
pubmed-meshheading:20567922-Prognosis,
pubmed-meshheading:20567922-Retrospective Studies,
pubmed-meshheading:20567922-Survival Analysis,
pubmed-meshheading:20567922-Thymoma,
pubmed-meshheading:20567922-Thymus Neoplasms,
pubmed-meshheading:20567922-Tumor Markers, Biological
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
New predictors of response to neoadjuvant chemotherapy and survival for invasive thymoma: a retrospective analysis.
|
|
pubmed:affiliation |
Department of Thoracic Surgery, Fondazione and Policlinico Tor Vergata University, Rome, Italy. mineo@med.uniroma2.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
